IMU-201

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameIMU-201
Drug Alias NamePD-1 cancer vaccine (Imugene)IMU-201APi-2568KEY-VaxxPD1-Vaxx +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsColorectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo ClinicThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southampton
Inactive CompaniesImugene Ltd
Active IndicationsColorectal Neoplasms
Inactive IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsCarcinoma, Large Cell +[4] 

Other Information

ATC CodeN/A
Related LinksN/A